New Educational Campaign by Tonix Pharmaceuticals
Gastroparesis is a condition that causes the stomach to take longer than usual to empty its contents into the small intestine, which can hinder the absorption of oral medications. In an effort to educate the public, Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) has recently unveiled a significant new campaign titled "Does Your Migraine Pill Work Every Time?" at the National PAINWeek Conference held in Las Vegas.
Understanding Gastroparesis and Its Effects
This condition can lead to a range of problems, including nausea, vomiting, and abdominal discomfort. Research conducted over the past four decades has demonstrated a strong correlation between gastroparesis and migraines, indicating that this digestive slowdown can happen before, during, or even between migraine episodes. Consequently, oral medications may not deliver relief in a timely manner, which can be frustrating for those affected.
Alternative Treatment Options
Dr. Deborah I. Friedman, a prominent Neuro-Ophthalmologist, highlighted the advantages of non-oral migraine treatments such as nasal sprays and injectable medications. Unlike traditional pills, these alternatives can quickly move through the digestive system, sometimes providing relief in as little as 10 minutes. Dr. Friedman encourages individuals experiencing migraines to discuss these faster-acting options with their healthcare providers.
Empowering Patients for Better Migraine Management
Shoshana Lipson, Executive Director of Migraine Meanderings™, emphasized the importance of self-advocacy for patients managing migraines. By understanding why some oral medications may not work effectively and being aware of non-oral treatment options, individuals can significantly improve their quality of life.
New Resources and Educational Initiatives
To further support patients, Tonix is launching a dedicated educational website designed to clarify the connection between gastroparesis and migraines. This platform will act as a valuable resource for those looking to understand why certain migraine medications may not be effective.
Tonix Pharmaceuticals and Its Commitment to Innovation
Tonix Pharmaceuticals is committed to advancing biopharmaceutical solutions, particularly in the field of central nervous system (CNS) disorders. The company is currently focused on submitting a New Drug Application (NDA) for TNX-102 SL, an innovative candidate aimed at managing fibromyalgia, which is expected to be filed later this year. Additionally, Tonix is exploring various treatment options for conditions such as cocaine intoxication and autoimmune diseases.
Contact and Further Information
For those interested in learning more about Tonix Pharmaceuticals and their latest campaign, the company's website offers comprehensive resources. Both patients and healthcare professionals can benefit from the essential information provided.
Frequently Asked Questions
What is gastroparesis and how does it affect migraine treatment?
Gastroparesis slows the stomach's ability to empty, potentially delaying oral medication absorption, which can impact migraine relief.
What are non-oral migraine medications?
Non-oral treatments include nasal sprays and injectables that bypass the digestive system for quicker effects.
How can patients learn more about gastroparesis?
Tonix is launching a new website dedicated to educating patients about gastroparesis and its relation to migraines.
Who is leading the campaign on migraine awareness?
Deborah I. Friedman and Shoshana Lipson are notable figures advocating for better patient education regarding migraine treatments.
What is Tonix Pharmaceuticals’ focus?
Tonix focuses on developing treatments for CNS disorders, with an emphasis on innovative approaches to medication.
